Trials / Terminated
TerminatedNCT01790113
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 303 (actual)
- Sponsor
- Arthrex, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, Randomized, Multicenter Study comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder to the Univers™ II Shoulder Prosthesis in patients with a degenerative joint disease.
Detailed description
The purpose of this study is to demonstrate non-inferiority of the Arthrex Eclipse™ Shoulder Prosthesis to the Arthrex Univers™ II Shoulder Prosthesis for the treatment of degenerative joint disease in subjects who are candidates for total shoulder replacement. Non-inferiority in terms of safety and effectiveness will be measured by a 2 year composite clinical success (CCS) that requires functional improvement, radiographic success, absence of reoperations and revision, and lack of serious device-related adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Univers™ | Control |
| DEVICE | Eclipse™ Total Shoulder Replacement | Investigational |
Timeline
- Start date
- 2013-02-04
- Primary completion
- 2019-06-07
- Completion
- 2019-06-07
- First posted
- 2013-02-13
- Last updated
- 2021-02-03
- Results posted
- 2021-01-29
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01790113. Inclusion in this directory is not an endorsement.